The most variable step in liquid biopsy, now automated.
Avant Source™ standardizes sample preparation, so every cell-free DNA result is reliable, scalable, and ready for the clinic.
The science
Liquid biopsy is only as reliable as its sample preparation.
Today the workflow is largely manual: dozens of labor-intensive steps that vary lab to lab and reduce tumor-derived cell-free DNA recovery. Avant Source automates the front end with a cartridge-based system born from a decade of microfluidics and nucleic-acid research at the University of Virginia.
Automated cfDNA extraction
Plasma in, purified cfDNA out, with no pipetting, no drift, no hands-on variability.
Cartridge-grade consistency
A standardized, fully integrated workflow that scales across labs, reliable enough for routine clinical use.
From plasma to purified cfDNA
65%+ higher cfDNA yield vs. semi-automated prep
One cartridge. Plasma in, purified cfDNA out.
Cell-free DNA is isolated directly from plasma, with no manual pipetting to introduce loss or variability.
Coming 2027: a new instrument
The next generation is taking shape.
